Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

AstraZeneca · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
carcinomalung-cancer
carcinoma, non- small cell lung, ncslc, double-blind, pd-l1, medi4736, durvalumab, dfs, os, mrd+, lung cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 868426
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.